JPRN-jRCTs071180022已完成2 期
Multicenter randomized phase II study prevention of chemotherapy induced stomatitis with the steroid component mouthwash in woman with breast cancer - Multicenter randomized phase II study prevention of chemotherapy induced stomatitis with the steroid component mouthwash in woman with breast cancer
Eguchi Susumu0 个研究点目标入组 121 人开始时间: 2019年2月22日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 121
研究概览
简要总结
We conducted a multicenter, randomized, controlled phase II trial. Patients with early-stage breast cancer scheduled for epirubicin and cyclophosphamide (EC) or taxotere and cyclophosphamide (TC) therapies were allocated in a 1:1 ratio to the study and control groups.The incidence of stomatitis was 55% in the control group and 38% in the study group. The grade of stomatitiswas significantly lower in the study group.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 80age old（—）
- 性别
- Female
入选标准
- •Patients who is going to have chemotherapy, patients without stomatitis
排除标准
- •Patients who have metastatic disease
研究者
相似试验
已完成
不适用
A Phase II randomized multicenter study to assess the efficacy of lenalidomide with or without erythropoietin and granulocyte-colony stimulating factor in patients with low and intermediate-1 risk myelodysplastic syndrome.Myelodysplastic syndrome (MDS)NL-OMON20915Stichting Hemato-Oncologie voor Volwassenen Nederland (HOVON) P/a HOVON Data CenterErasmus MC - Postbus 2040; 3000 CA Rotterdam; Tel: +31 10 704 1560 Fax: +31 10 704 1028; e-mail: hdc@erasmusmc.nl200
招募中
不适用
A randomized phase II multicenter study to assess the tolerability and efficacy of the addition of ibrutinib to 10-day decitabine in UNFIT (i.e. HCT-CI >= 3) AML and high risk myelodysplasia (MDS) (IPSS-R > 4.5) patients aged >= 66 years.A study in the frame of the masterprotocol of parallel randomized phase II studies in UNFIT-older AML/high-risk MDS patients.Acute Myeloid Leukemia (AML), MyelodysplasiaNL-OMON19923HOVON Data Center185
已完成
2 期
Study of NV-101 for Safety and Efficacy in Pediatric Dental Patients Undergoing ProceduresAnesthesia, DentalNCT00309322Novalar Pharmaceuticals, Inc.150
已完成
2 期
A Study to Evaluate Bevacizumab and Chemotherapy or Tarceva in Treating Recurrent or Refractory NSCLC (Non-Small Cell Lung Cancer)Non-Small-Cell Lung CarcinomaNeoplasm Recurrence, LocalNCT00095225Genentech, Inc.122
Unknown
2 期
Phase II Study in the Treatment of Patients With Advanced Mucinous MelanomaAdvanced Mucosal MelanomaNCT03941795Peking University Cancer Hospital & Institute99